|
Study: Teva's Copaxone the Better Treatment Option for MS
Teva Pharmaceutical’s multiple sclerosis (MS) agent Copaxone is a better treatment for patients with relapsing-remitting MS compared with interferon beta drug products, a recent study found. This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives